Related Article

This Perspective refers to the following Article:
Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668
Joel M. Reid, Chad A. Walden, Rui Qin, Katie L. Allen Ziegler, John L. Haslam, Roger A. Rajewski, Roger Warndahl, Cindy L. Fitting, Daniel Boring, Eva Szabo, James Crowell, Marjorie Perloff, Ling Jong, Brent A. Bauer, Sumithra J. Mandrekar, Matthew M. Ames, and Paul J. Limburg, for the Cancer Prevention Network